Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company with two main segments: the United States and International. The United States segment generates revenue primarily from selling prescription drugs (approximately 60%) and a variety of retail products, including health, wellness, beauty, and general merchandise (approximately 30%). The International segment also sells prescription drugs and consumer products, contributing around 10% to total revenue. Factors supporting endurance include a large store footprint and established brand recognition, while challenges may arise from regulatory pressures and competition in the retail pharmacy space.
—
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company with two main segments: the United States and International. The United States segment generates revenue primarily from selling prescription drugs (approximately 60%) and a variety of retail products, including health, wellness, beauty, and general merchandise (approximately 30%). The International segment also sells prescription drugs and consumer products, contributing around 10% to total revenue. Factors supporting endurance include a large store footprint and established brand recognition, while challenges may arise from regulatory pressures and competition in the retail pharmacy space.
—
Daily adjusted close
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company with two main segments: the United States and International. The United States segment generates revenue primarily from selling prescription drugs (approximately 60%) and a variety of retail products, including health, wellness, beauty, and general merchandise (approximately 30%). The International segment also sells prescription drugs and consumer products, contributing around 10% to total revenue. Factors supporting endurance include a large store footprint and established brand recognition, while challenges may arise from regulatory pressures and competition in the retail pharmacy space.